The Effect of Recombinant Human Thrombopoietin(rhTPO) on Septic Shock With Thrombocytopenia a Prospective, Multi-center, Open-label, ,Randomized, Placebo-controlled Study.

Next Previous
Trial Profile

The Effect of Recombinant Human Thrombopoietin(rhTPO) on Septic Shock With Thrombocytopenia a Prospective, Multi-center, Open-label, ,Randomized, Placebo-controlled Study.

Not yet recruiting
Phase of Trial: Phase II/III

Latest Information Update: 15 Mar 2016

At a glance

  • Drugs Thrombopoietin (Primary)
  • Indications Thrombocytopenia
  • Focus Therapeutic Use

    • Most Recent Events

    • 15 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top